Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)
China · Delayed Price · Currency is CNY 6.12
-0.25 (-3.92%)
May 21, 2026, 3:04 PM CST
SHE:300289 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -25.7 | -22.98 | -75.1 | 15.34 | -56.27 | 22.42 |
Depreciation & Amortization | 48.29 | 48.29 | 59.22 | 63.03 | 62.91 | 58.94 |
Other Amortization | 7.52 | 7.52 | 7.84 | 7.8 | 5 | 3.05 |
Loss (Gain) From Sale of Assets | -0.59 | -0.59 | - | - | -0.45 | -1.34 |
Asset Writedown & Restructuring Costs | 0.2 | 0.2 | 71.13 | 15.11 | 30.69 | 21.72 |
Loss (Gain) From Sale of Investments | -6.27 | -6.27 | -5.93 | -1.77 | -4.13 | -0.07 |
Provision & Write-off of Bad Debts | -3.66 | -3.66 | -0.78 | 11.66 | 26.99 | 4.42 |
Other Operating Activities | 10.76 | 11.05 | -2.05 | 10.13 | 22.26 | 25.5 |
Change in Accounts Receivable | 4.47 | 4.47 | 48.75 | 43.98 | 6.25 | 2.85 |
Change in Inventory | -11.58 | -11.58 | -10.23 | 7.78 | 2.88 | -25.24 |
Change in Accounts Payable | 0.72 | 0.72 | -26.81 | -34.44 | 16.68 | 11.86 |
Operating Cash Flow | 26.15 | 29.16 | 62.41 | 130.8 | 108.93 | 119.06 |
Operating Cash Flow Growth | -59.51% | -53.27% | -52.29% | 20.07% | -8.50% | -12.17% |
Capital Expenditures | -20.94 | -17.59 | -29.23 | -18.69 | -39.12 | -44.5 |
Sale of Property, Plant & Equipment | 0.51 | 0.51 | - | - | 0.59 | 2.14 |
Investment in Securities | 80 | -65 | -17.45 | -338.27 | -178.83 | - |
Other Investing Activities | 6.78 | 6.1 | 7.57 | 3.62 | 4.24 | 0.03 |
Investing Cash Flow | 66.35 | -75.98 | -39.11 | -353.33 | -213.11 | -42.33 |
Long-Term Debt Issued | - | - | - | - | 0.72 | - |
Total Debt Issued | - | - | - | - | 0.72 | - |
Long-Term Debt Repaid | - | -2.77 | -4.63 | -12.06 | -13.87 | -52.65 |
Total Debt Repaid | -2.77 | -2.77 | -4.63 | -12.06 | -13.87 | -52.65 |
Net Debt Issued (Repaid) | -2.77 | -2.77 | -4.63 | -12.06 | -13.15 | -52.65 |
Issuance of Common Stock | - | - | - | - | - | 550.97 |
Common Dividends Paid | - | - | -5.44 | -0.2 | -10.88 | -0.4 |
Other Financing Activities | -10.41 | -6.11 | -6.4 | 1.5 | -0.73 | 1.23 |
Financing Cash Flow | -13.18 | -8.88 | -16.47 | -10.76 | -24.76 | 499.15 |
Foreign Exchange Rate Adjustments | -0.48 | -0.48 | -0.3 | -0.49 | -0.13 | 0.17 |
Net Cash Flow | 78.85 | -56.18 | 6.53 | -233.79 | -129.07 | 576.04 |
Free Cash Flow | 5.21 | 11.57 | 33.18 | 112.11 | 69.81 | 74.56 |
Free Cash Flow Growth | -89.95% | -65.12% | -70.40% | 60.58% | -6.36% | -30.43% |
Free Cash Flow Margin | 1.64% | 3.55% | 8.96% | 24.29% | 9.89% | 13.22% |
Free Cash Flow Per Share | 0.01 | 0.02 | 0.06 | 0.21 | 0.12 | 0.17 |
Cash Income Tax Paid | 34.53 | 34.5 | 43.48 | 61.42 | 60.55 | 60.69 |
Levered Free Cash Flow | 29.27 | 41.63 | 23.88 | 78.37 | 51.4 | 94.9 |
Unlevered Free Cash Flow | 29.39 | 41.76 | 24.07 | 78.78 | 52.21 | 96.24 |
Change in Working Capital | -4.39 | -4.39 | 8.08 | 9.51 | 21.95 | -15.57 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.